News

Malaria Prophylaxis: Destination Designates Drug

Publish date: April 21, 2011

 

FROM THE ANNUAL MEETING OF THE AMERICAN COLLEGE OF PHYSICIANS

Dr. Miller reported having financial relationships with Pfizer, Cubist Pharmaceuticals, GlaxoSmithKline, and Merck. He has been a consultant with Theravance.

Pages

Recommended Reading

Study of Human Parechovirus in U.S. Finds 7% Prevalence
MDedge Family Medicine
C. difficile Colitis Hikes Hospital Costs
MDedge Family Medicine
Stomach, Esophageal Cancer Risks Increased in AIDS Patients
MDedge Family Medicine
Four-Drug Fixed-Dose Combo for TB Found Noninferior
MDedge Family Medicine
Topical Suffocants Effective for Resistant Head Lice
MDedge Family Medicine
Interventions to Reduce MRSA Have Conflicting Results
MDedge Family Medicine
Probiotic Treatment Halved Recurrent UTI Risk
MDedge Family Medicine
Alcohol Use Disorders Up Death Risk for Inpatients With Infections
MDedge Family Medicine
Vaccine Safety Information: Whom Do Parents Trust?
MDedge Family Medicine
FDA Sends Warning Letters to Four Hand Sanitizer Manufacturers
MDedge Family Medicine